{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:17:43Z","timestamp":1786994263629,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mito.2026.102138","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:08:43Z","timestamp":1772294923000},"page":"102138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Late-onset TK2 deficiency in adults: Long-term clinical outcomes of deoxynucleoside therapy"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-676X","authenticated-orcid":false,"given":"Hacer","family":"Durmus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman","family":"Gedikba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"\u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezan","family":"Mergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-6518","authenticated-orcid":false,"given":"Esen","family":"K\u0131yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim G\u00fcl\u015fen","family":"Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2026.102138_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/hmg\/ddr438","article-title":"Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions","volume":"21","author":"Tyynismaa","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2026.102138_b0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13023-019-1071-z","article-title":"Late-onset thymidine kinase 2 deficiency: a review of 18 cases","volume":"14","author":"Dominguez-Gonzalez","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.mito.2026.102138_b0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200138","article-title":"Clinical and Genetic Analysis of patients with TK2 Deficiency","volume":"10","author":"Ceballos","year":"2024","journal-title":"Neurology Genetics"},{"key":"10.1016\/j.mito.2026.102138_b0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ana.24922","article-title":"Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency","volume":"81","author":"Lopez-Gomez","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2026.102138_b0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ebiom.2019.07.042","article-title":"Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice","volume":"46","author":"Blazquez-Bermejo","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mito.2026.102138_b0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15252\/emmm.201404092","article-title":"Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency","volume":"6","author":"Garone","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mito.2026.102138_b0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13023-021-02030-w","article-title":"Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency","volume":"16","author":"Dominguez-Gonzalez","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.mito.2026.102138_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101879","article-title":"Remarkable clinical improvement with oral nucleoside treatment in a patient with adult-onset TK2 deficiency: a case report","volume":"76","author":"Bermejo-Guerrero","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2026.102138_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109159","article-title":"Doxecitine and doxribtimine treatment in an adult patient with thymidine kinase 2 deficiency","volume":"145","author":"Chow","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mito.2026.102138_b0050","doi-asserted-by":"crossref","unstructured":"Hernandez-Voth A, Sayas Catalan J, Corral Blanco M, et al. Deoxynucleoside therapy for respiratory involvement in adult patients with thymidine kinase 2-deficient myopathy. BMJ open respiratory research 2020;7.","DOI":"10.1136\/bmjresp-2020-000774"},{"key":"10.1016\/j.mito.2026.102138_b0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.25506","article-title":"Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy","volume":"86","author":"Dominguez-Gonzalez","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2026.102138_b0060","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213908","article-title":"Pyrimidine Nucleos(t)ide Therapy in patients with Thymidine Kinase 2 Deficiency: a Multicenter Retrospective Chart Review Study","volume":"105","author":"Dominguez-Gonzalez","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2026.102138_b0065","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jmedgenet-2017-105012","article-title":"Retrospective natural history of thymidine kinase 2 deficiency","volume":"55","author":"Garone","year":"2018","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mito.2026.102138_b0070","unstructured":"Wang J, El-Hattab AW, Wong LJC. TK2-Related Mitochondrial DNA Maintenance Defect, Myopathic Form. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews((R)). Seattle (WA)1993."},{"key":"10.1016\/j.mito.2026.102138_b0075","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/s41598-020-66940-8","article-title":"Growth Differentiation factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy","volume":"10","author":"Dominguez-Gonzalez","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724926000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724926000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:17:06Z","timestamp":1776410226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724926000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"alternative-id":["S1567724926000280"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2026.102138","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late-onset TK2 deficiency in adults: Long-term clinical outcomes of deoxynucleoside therapy","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2026.102138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Mitochondria Research Society. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102138"}}